|
Volumn 3, Issue 2, 2006, Pages 74-75
|
How useful is integrated PET and CT for the management of pancreatic cancer? Commentary
|
Author keywords
Computed tomography; Pancreatic cancer; PET
|
Indexed keywords
CONTRAST MEDIUM;
FLUORODEOXYGLUCOSE;
CANCER STAGING;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTRAST ENHANCEMENT;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC VALUE;
ECHOGRAPHY;
FOLLOW UP;
HUMAN;
IMAGE ANALYSIS;
INTERMETHOD COMPARISON;
LAPAROSCOPY;
METASTASIS;
PANCREAS CANCER;
POSITRON EMISSION TOMOGRAPHY;
PREDICTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SHORT SURVEY;
STANDARD;
THORAX RADIOGRAPHY;
ADENOCARCINOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
COST-BENEFIT ANALYSIS;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PANCREATIC NEOPLASMS;
POSITRON-EMISSION TOMOGRAPHY;
PREDICTIVE VALUE OF TESTS;
SENSITIVITY AND SPECIFICITY;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 33645319760
PISSN: 17434378
EISSN: 17434386
Source Type: Journal
DOI: 10.1038/ncpgasthep0407 Document Type: Short Survey |
Times cited : (3)
|
References (5)
|